1 min read

Given Imaging’s Sale to Covidien

Covidien agreed in December 2013 to buy Given Imaging for $30 per share, about $860 million net of cash and investments, and closed the deal in February 2014. Medtronic acquired Covidien in January 2015.

Miriam Bernstein

Miriam Bernstein is the pen name of Hasbara’s Resources desk. Articles on this desk are written and published automatically by artificial intelligence, with no person reviewing them before publication.

Covidien agreed on December 8, 2013, to acquire Given Imaging for $30 per share in cash, a transaction valued at approximately $860 million net of cash and investments acquired. Covidien completed the purchase on February 27, 2014. PillCam joined Covidien’s gastrointestinal device business, and became part of Medtronic when Medtronic completed its acquisition of Covidien in January 2015.

Given Imaging, headquartered in Yokneam, Israel, developed PillCam and a broader range of digestive-system diagnostic and monitoring products. The purchase gave Covidien a capsule endoscopy business and expanded its gastrointestinal portfolio.

What the $860 million figure described

Covidien’s December 2013 announcement filed with the SEC offered $30 in cash for each outstanding Given Imaging share. It stated a total transaction value of approximately $860 million, net of cash and investments acquired. The SEC-filed acquisition announcement identifies PillCam as Given Imaging’s flagship swallowed capsule endoscope.

Covidien’s February 27, 2014 closing announcement confirms that the deal closed at the agreed $30 per share, approximately $860 million net of cash and short-term investments acquired. Covidien later reported different cash-consideration figures in accounting filings; those completion-accounting numbers use a different presentation from the announced net transaction value and offer price.

From Covidien to Medtronic

Medtronic completed its acquisition of Covidien on January 26, 2015. Its SEC-filed completion announcement states that the two companies combined under Medtronic plc. That corporate transaction placed Given Imaging’s product portfolio within Medtronic.

The ownership path ran from an Israeli device company to Covidien and then into Medtronic: Given Imaging to Covidien in 2014, followed by Covidien to Medtronic in 2015. The acquisitions changed the company behind the product, while PillCam remained a capsule endoscopy system for visualizing the digestive tract. See how Given Imaging developed PillCam and what clinicians use capsule imaging to examine.

Sources

  1. 1.https://www.sec.gov/Archives/edgar/data/1385187/000138518713000055/cov-2013120913_8xkxex991.htm
  2. 2.https://news.medtronic.com/2014-02-27-Covidien-Completes-Acquisition-of-Given-Imaging
  3. 3.https://www.sec.gov/Archives/edgar/data/1613103/000119312515020681/d859999dex991.htm

Accessibility

These settings are saved on this device.

Preview

Read clearly, your way

Adjust this page while you read. Explore resources

Text
Text sizeApplies across the site.
Colour and contrast
Theme
Motion
AnimationsMatch device follows your reduced motion setting.